Please login to the form below

Not currently logged in
Email:
Password:

Three directors join UK’s MHRA

Valerie Beral, Alexander Markham and David Webb join UK regulatory body

The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has named three new non-executive directors.

Valerie Beral, MHRA

Dame Valerie Beral, Prof Sir Alexander Markham and Prof David Webb will all join the board of the MHRA, which regulates the safety of medicines and medical devices in the UK.

Dame Valerie (pictured right) is director of the cancer epidemiology unit at the University of Oxford, where her research has included reproductive, hormonal and infectious agents in cancer.

She also helped lead the Million Women Study, which helped demonstrate that hormone replacement therapy increases a woman's risk of developing breast cancer.

Prof Markham is professor of medicine at the University of Leeds and a former CEO of the charity Cancer Research UK.

He is also director of the molecular medicine unit at St James's University Hospital and chairman of the NHS Connecting for Health Research Capability Programme, in addition to serving on a number of panels of the Medical Research Council.

David Webb, MHRA

Prof Webb (pictured left) is Christison professor of therapeutics and clinical pharmacology at the University of Edinburgh.

His research has focused on internal medicine, hypertension and cardiovascular risk management, and he established Edinburgh University's Wellcome Trust cardiovascular research initiative and centre for cardiovascular science.

In addition to his academic role, he is the current leader of the Scottish Translational Medicine and Therapeutics Initiative (STMTI), established by the Wellcome Trust.

“I'm delighted that Dame Valerie, Sir Alex and Professor Webb have accepted appointments as non-executive directors of the MHRA,” said Sir Gordon Duff, chair of the MHRA.

“They will bring highly relevant experience and expertise to our board at a time of significant development of the Agency, and will contribute importantly to our strategic leadership.

30th July 2013

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...

Latest intelligence

Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....